20977 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] Leukaemia inhibitory factor [LIF]
System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein
#2TISSUE REGENERATIVE MULTI-DRUG COCKTAIL AND APPARATUS FOR DELIVERY THEREOF
#3NOVEL THERAPEUTIC COMPRISING A SECRETOME FROM MESENCHYMAL STEM CELLS OF UMBILICORD TISSUE OR WHARTON'S JELLY
#4METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS
#5COMPOSITIONS AND METHODS OF MODULATING ENDOCHONDRAL OSSIFICATION AND BONE FORMATION
#6Compositions and Methods for Promoting Angiogenesis in the Eye
#7Selective recovery
#8LIF THERAPY FOR INDUCING INTESTINAL EPITHELIAL CELL REGENERATION
#9IMPROVED WEIGHT LOSS THERAPY
#10System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein
#11Selective recovery
#12Compositions and methods of modulating endochondral ossification and bone formation
#13Mammalian birth tissue composition for tumor treatment
#14Selective recovery
#15Composition containing endometrial decidual cells for treating damage to the endometrium or enhancing implantation functions
#16Selective recovery
#17Adrenomedullin therapy to improve fetal implantation
#18Neurotherapeutic nanoparticle compositions comprising leukemia inhibitory factor
#19Selective recovery
#20Methods for treating back or neck pain caused by NGF using a therapeutic agent comprising REN-1820, ALE-0540 and capsaicin
#21Selective recovery
#22Targeting peptides for directing adeno-associated viruses (AAVs)
#23WOUND HEALING COMPOSITION
#24Compounds suitable for the treatment of myeloproliferative neoplasms as well as methods for the diagnosis/prognosis of myeloproliferative neoplasms
#25Inhibition of the tumorigenic potential of tumor stem cells by LIF and BMPs
#26Compositions and methods for preventing cardiac arrhythmia
#27Compositions and methods for preventing cardiac arrhythmia
#28Recombinant AAV capsid protein
#29Sterilized and decellularized extracellular matrix for treating cardiac arrhythmia
#30Use of endogenous antioxidant proteins in the treatment of stroke
#31Treating cardiovascular tissue
#32LEUKEMIA INHIBITORY FACTOR (LIF) FOR USE IN REPRESSING HUMAN PAPILLOMAVIRUS (HPV) TRANSCRIPTION
#33LYMPHOCYTE CONTROL OF OBESITY AND INSULIN RESISTANCE
#34USE OF GALANIN IN A METHOD OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS
#35Enhanced ocular neuroprotection and neurostimulation
#36Compositions and methods for preventing cardiac arrhythmia
#37Inhibition of the tumorigenic potential of tumor stem cells by LIF and BMPS
#38METHODS AND MATERIALS RELATING TO ENHANCED PRODUCTION OF DOPAMINE NEURONS
#39ENHANCED RECOVERY FOLLOWING OCULAR SURGERY
#40Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions
#41Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases
#42Compositions consisting essentially of TGF-β, BMP-2 FGF-4, leukemia inhibitory factor, IGF-1, IL-6 and H-α-thrombin
#43ENHANCED OCULAR NEUROPROTECTION AND NEUROSTIMULATION
#44ENHANCED RECOVERY FOLLOWING OCULAR SURGERY
#45Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin
#46Methods for the treatment and prophylaxis of demeyelinating disease
#47Method for regulating neuron development and maintenance
#48Method of modulating fertility in animals
#49Enhanced ocular neuroprotection and neurostimulation
#50Enhanced ocular neuroprotection and neurostimulation
#51Enhanced recovery following ocular surgery
#52Use of GnRH agonists to support the luteal phase during infertility treatment
#53Cosmetic/dermatological applications of LIF
#54Compositions of leukaemia inhibitory factor
#55Stem and progenitor cell capture for tissue regeneration